Medical and preventive institutions of the Republic of Tatarstan received 1000 packages of an innovative drug for the treatment of patients with COVID-19

On April 14, 2021, healthcare institutions of the Republic of Tatarstan accepted a centralized delivery of 1,000 packages of a drug preparation for the treatment of moderate forms of the new coronavirus infection COVID-19 – a domestic biotechnological drug preparation Artlegia – as part of a charity campaign conducted by its manufacturer, the R-Pharm group of companies.

The Republic of Tatarstan is implementing a number of measures aimed at countering the spread of the SARS-CoV-2 coronavirus. For more than a year, since the beginning of the pandemic, various measures have been regularly carried out to improve the sanitary and epidemiological situation.